Dr. Jason Blauwet earned his Doctor of Pharmacy from The University of Iowa in 2000. He went on to complete a specialty residency at The Children’s Hospital in Denver, CO. After completing his residency, he practiced as a pediatric specialist at Memorial Hospital in Colorado Springs before returning to The Children’s Hospital in 2004 as a pediatric surgery specialist. In 2008 he accepted the position of Pediatric Clinical Coordinator and was promoted to Assistant Director of Pharmacy at P/SL and and The Rocky Mountain Hospital for Children before ultimately becoming Director of Pharmacy. Dr. Blauwet is a Board Certified Pharmacotherapy Specialist and has been instrumental in the development of the PGY1 residency program, serving in the role as the first program director. His research interests include optimization of pharmacotherapy regimens for pediatric patients as well as process improvement within a large tertiary referral medical system. Dr. Blauwet is an avid skier and cyclist, and has completed several endurance races in Colorado including the Leadville 100 and the Triple Bypass.

Dr. Sarah Breeding received her Doctor of Pharmacy degree from the University of Missouri – Kansas City in 2012. After graduation, she moved to Denver, CO and completed a PGY-1 residency at Presbyterian/St. Luke’s Medical Center & the Rocky Mountain Hospital for Children. At the conclusion of the residency year, she accepted a position to stay at P/SL as a Pediatric Clinical Pharmacy Specialist. Dr. Breeding is a primary preceptor for University of Wyoming and Regis University students in general pediatrics. In addition, she has recently stepped into the role of Residency Program Director. Dr. Breeding is a member of the Pharmacy Unit Based Council, Code Blue Committee, the Pediatric and Neonatal Intensive Care Unit rounding teams, and is involved in pharmacy and nursing education. She is also a member of ASHP and the Pediatric Pharmacy Advocacy Group.

Dr. Cristie Gilbreth obtained a Pharm.D. from the University of Washington. Following her Pharm.D. Dr. Gilbreth completed a PGY1 residency at Good Samaritan Hospital in Puyallup Washington. Dr. Gilbreth is board certified in oncology and has been a BMT/oncology Clinical Specialist to PSL for 7 years. Dr. Gilbreth actively precepts students from the Schools of Pharmacy at The University of Colorado and The University of Wyoming. Areas of interest include the treatment of GVHD and the management of immune suppression. Committee membership cancer care and nutritional support committees.

Dr. Erin Kraemer received her Bachelor of Science in Pharmacy at Northeastern University in Boston, Massachusetts and her Doctor of Pharmacy at University of Colorado in Denver, Colorado. She had worked at Boston Children’s Hospital for four years covering areas of bone marrow transplant, pediatric oncology, cardiac intensive care, PICU, NICU and pediatric nutrition. While in Boston, she had presented three posters at the ASHP midyear. Dr. Kraemer moved to Colorado to work as a neonatal clinical pharmacist at Presbyterian St. Luke’s Medical Center. She presented a poster titled “A Prospective Evaluation of Amikacin Dosing in the NICU” at the American Academy of Pediatrics, Section on Perinatal Pediatrics in Keystone, Colorado. She also presented a poster titled “Performance Improvement Activities in Therapeutic Drug Level Monitoring of Vancomycin in a Neonatal Intensive Care Unit” at Pediatric Pharmacy Advocacy Group in Scottsdale, Arizona. Currently, Dr. Kraemer is a pediatric clinical specialist at the Rocky Mountain for Children Hospital (RMHC) at Presbyterian St. Luke’s Medical Center. She is the Pharmacy Research Investigator for the COG program (Children Oncology Group) at RMHC. She is PALS and ACLS certified. She has been a preceptor for the past 23 years for University of Wyoming.

Dr. David Oeser earned his Bachelor of Pharmacy from Washington State University in 1984. In 1987, he completed his Doctor of Pharmacy at the University of Washington as well as a two-year advanced pharmacy practice residency at the University of Washington Medical Center. After completing his residency, he practiced as an Oncology Pharmacist at the Virginia Mason Medical Center in Seattle and then took the position of Clinical Coordinator at Evergreen Hospital Medical Center in Kirkland, Washington and then accepted a position as Clinical Pharmacy Coordinator at Lawrence Memorial Hospital in Lawrence, Kansas where he served for five years. Upon moving to Houston, Texas he took a position as Pharmacy Clinical Practice Specialist at the University of Texas MD Anderson Cancer Center where he specialized in critical care and nutrition support until moving to Denver where he accepted a position at Presbyterian/St. Luke’s (P/SL) Medical Center as a Clinical Pharmacist. He was subsequently promoted to Medication Safety Coordinator, and in 2007, accepted the position of Director of Pharmacy. He has held a number of faculty appointments including Clinical Instructor of Pharmacy Practice at the University of Washington School of Pharmacy, Clinical Assistant Professor of Pharmacy Practice at the University of Kansas School of Pharmacy, Assistant Clinical Professor at the University of Houston College of Pharmacy. Currently Dr. Oeser serves as Clinical Instructor at the University of Colorado School of Pharmacy and Adjunct Clinical Faculty in Pharmacy for the University of Wyoming College of Pharmacy. His research interests are varied and he serves as a scientific member of the HealthONE Investigational Review Board. He is the author of numerous peer-reviewed articles and is certified in BCLS, ACLS, and PALS. Practice interests include pharmacy administration, clinical management, critical care, oncology supportive care, nutrition support, teaching, and medication safety. Dr. Oeser is an avid guitarist who enjoys mountain biking, skiing, backpacking, squash, art, viticulture and, above all, his family.

Ms. Joan Orgeldinger completed her Bachelor of Science Degree in Pharmacy in 1989 at the University of Colorado. She has practiced in a variety of pharmacy settings including inpatient, drug information, training/educator, and outpatient pharmacy. Since 1998, she has been an inpatient pharmacist which is her preferred area of practice. She is currently an Assistant Director of Pharmacy and the Medication Safety Coordinator at P/SL. She is actively involved in working with nursing staff and the hospital’s CPOE system. Joan is passionate about improving patient safety at P/SL and strives to improve communication among caregivers in an effort to make this happen. She currently serves as a member of the P&T Committee at PSLMC and chairs the Medication Safety Team Committee. Joan is an outdoor enthusiast and enjoys skiing, cycling, and loves to travel.

Dr. Peter Schlickman received his Doctor of Pharmacy from University of Iowa in 2005. After graduation, he completed a PGY-1 Residency at Methodist Dallas Medical Center in Dallas, TX followed by a PGY-2 Oncology Specialty Residency at the University of Michigan Hospital and Clinics in Ann Arbor, MI and Board Certification in Oncology Pharmacy. He then spent the next five years working as the Hematology/Oncology Pharmacy Specialist at the Eastern Colorado Health Care System Denver VA Medical Center before joining the bone marrow transplant team at Presbyterian/St. Luke’s Medical Center in 2012. He joined the Sarah Cannon Research Institute Drug Development Unit when it opened in 2014 and is the research pharmacist for their phase 1 clinical trial team. He is an active member of the Hematology/Oncology Pharmacy Association and has served on several different committees for the organization.

Dr. Amelia Woods obtained her Doctor of Pharmacy from University of Iowa in 2003. After graduation, she spent two years working at First Choice Healthcare in Omaha, Nebraska, where she was involved in home healthcare drug therapy management and was a member of the Palliative Care committee and National Home Infusion Association. Dr. Woods then moved to Denver, CO to work for Presbyterian St. Luke’s Medical as a staff pharmacist and later accepted the Critical Care clinical specialist position. Dr. Woods is a primary preceptor for University of Colorado, University of Wyoming and Regis University. Dr. Woods is Board Certified in Pharmacotherapy and currently participates on the Pharmacy Unit Based Council, Nutritional Support, Critical Care, Residency Advisory and Transplant Pharmacist Committees. She is also member of ACCP and Society of Critical Care Medicine.